Position in NGNE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,319,814
+$1,427,361 QoQ
Shares Held
73,762
+70.3% QoQ
Ownership
0.369%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 111 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in NGNE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. NGNE ranks #76 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 6 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 | |
| 8 | EXEL |
Exelixis, Inc.
|
275,209 | $14,974,121 |
All Filings in NGNE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,319,814 | 73,762 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $892,453 | 43,323 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $684,240 | 39,483 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||